SUNPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 1 973.5 INR 1.67% Market Closed

Market Cap: ₹4.7T

	Sun Pharmaceutical Industries Ltd BSE:524715	IN
N	Nomura Research Institute Ltd SWB:NR7	JP
T	Tocvan Ventures Corp CNSX:TOC	CA
	ExpreS2ion Biotech Holding AB F:5JD0	SE
L	Laboratory Corporation of America Holdings SWB:LAB	US
N	Nine Dragons Paper (Holdings) Ltd XMUN:N3Y	HK
	MFA Financial Inc NYSE:MFA	US
	Ponce Financial Group Inc NASDAQ:PDLB	US
A	Arkema SA DUS:V1S	FR
N	Nine Dragons Paper (Holdings) Ltd OTC:NDGPY	HK
B	Bangchak Corporation PCL SET:BCP	TH

Profitability Summary

Sun Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 80%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

22% > 24%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

19% > 19%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

8% > 16%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC